Reactivation of the previously silenced cytomegalovirus major immediate- early promoter in the mouse liver: Involvement of NFκB

Journal of Virology

Volumn 72, Issue 1, 1998, Pages 180-190

  Löser, Peter ^a   Jennings, Gary S ^b   Strauss, Michael ^a,b   Sandig, Volker ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTICLE; CYTOMEGALOVIRUS; ENHANCER REGION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE TRANSFER; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; VIRUS EXPRESSION; VIRUS REACTIVATION; VIRUS TRANSCRIPTION;

EID: 2642673611     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.1.180-190.1998     Document Type: Article

References (65)

1. Armentano, D., J. Zabner, C. Sacks, C. C. Sookdeo, M. P. Smith, J. A. St. George, S. C. Wadsworth, A. E. Smith, and R. Gregory. 1997. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J. Virol. 71:2408-2416.
2. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
3. Baeuerle, P. A., and D. Baltimore. 1996. NF-κB: ten years after. Cell 87:13-20.
4. Barr, D., J. Tubb, D. Ferguson, A. Scaria, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151-155.
5. Baskar, J. F., P. P. Smith, G. Nilaver, R. A. Jupp, S. Hoffmann, N. J. Peffer, D. J. Tenney, A. M. Colberg-Poley, P. Ghazal, and J. A. Nelson. 1996. The enhancer domain of the human cytomegalovirus immediate-early promoter determines cell type-specific expression in transgenic mice. J. Virol. 70:3207-3214.
6. Bellas, R. E., J. S. Lee, and G. E. Sonenshein. 1995. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J. Clin. Invest. 96:2521-2527.
7. Bertrand, F., C. Philippe, P. J. Antoine, L. Baud, A. Groyer, J. Capeau, and G. Cherqui. 1995. Insulin activates nuclear factor NFκB in mammalian cells through a Raf-1-mediated pathway. J. Biol. Chem. 270:24435-24441.
8. S. Boshart, M., F. Weber, G. Jahn, K. Dorsch-Häsler, B. Fleckenstein, and W. Schaffner. 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41:521-530.
9. Bruder, J. T., and I. Kovesdi. 1997. Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression. J. Virol. 71:398-404.
10. Clesham, G. J., H. Brown, S. Efstathiou, and P. L. Weissberg. 1996. Enhancer stimulation unmasks latent gene transfer after adenovirus-mediated gene delivery to human vascular smooth muscle cells. Circ. Res. 79:1188-1195.
11. Cressman, D. E., L. E. Greenbaum, B. A. Haber, and R. Taub. 1994. Rapid activation of post-hepatectomy factor/nuclear factor κB in hepatocytes, a primary response in the regenerating liver. J. Biol. Chem. 269:30429-30435.
12. Cressman, D. E., L. E. Greenbaum, R. A. DeAngelis, G. Ciliberto, E. E. Furth, V. Poli, and R. Taub. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274:1379-1383.
13. Dai, Y., M. Roman, R. K. Naviaux, and I. M. Verma. 1992. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc. Natl. Acad. Sci. USA 89:10892-10895.
14. Dai, Y., E. M. Schwarz, D. Gu, W.-W. Zhang, N. Sarvetnick, and I. M. Verma. 1995. Cellular and humoral immune response to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allow for long-term expression. Proc. Natl. Acad. Sci. USA 92:1401-1405.
15. 14a. Essani, N. A., McGuire, G. M., Manning, A. M., and H. Jaeschke. 1996. Endotoxin-induced activation of the nuclear transcription factor κB and expression of E-selectin messanger RNA in hepatocytes, Kupffer cells, and endothelial cells in vivo. J. Immunol. 156:2956-2963.
16. Fietze, E., S. Prösch, P. Reike, J. Stein, W.-D. Döcke, G. Staffa, S. Löning, S. Devaux, F. Emmerich, R. von Baehr, D. H. Krüger, and H.-D. Volk. 1994. Cytomegalovirus infection in transplantation patients. Transplantation 58: 675-680.
17. FitzGerald, M. J., E. M. Webber, J. R. Donovan, and N. Fausto. 1995. Rapid DNA binding by nuclear factor κB in hepatocytes at the start of liver regeneration. Cell Growth Differ. 6:417-127.
18. Freedman, A. R., R. J. Sharma, G. J. Nabel, S. G. Emerson, and G. E. Griffin. 1992. Cellular distribution of nuclear factor κB binding activity in rat liver. Biochem. J. 287:645-649.
19. Furth, P. A., L. Hennighausen, C. Baker, B. Beatty, and R. Woychick. 1991. The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res. 19:6205-6208.
20. Ghazal, P., H. Lubon, B. Fleckenstein, and L. Hennighausen. 1987. Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc. Natl. Acad. Sci. USA 84:3658-3662.
21. Gruber, P. J., A. Torres-Rosado, M. L. Wolak, and T. Leff. 1994. Apo Ciii gene transcription is regulated by a cytokine inducible NF-κB element. Nucleic Acids Res. 22:2417-2422.
22. Guo, Z. S., L.-H. Wang, R. C. Eisensmith, and S. C. L. Woo. 1996. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther. 3:802-810.
23. Hansen, S. K., P. A. Baeuerle, and F. Blasi. 1994. Purification, reconstitution, and IkB association of the c-Rel-p65 (RelA) complex, a strong activator of transcription. Mol. Cell. Biol. 14:2593-2603.
24. Hattori, M., A. Tugores, J. K. Westnick, L. Veloz, H. L. Leffert, M. Karin, and D. A. Brenner. 1993. Activation of activating protein 1 during hepatic acute phase response. Am. J. Physiol. 264:G95-G103.
25. Hickman, A. E., R. W. Malone, K. Lehmann-Bruinsma, T. R. Sih, D. Knoell, F. C. Szoka, R. Walzern, D. M. Carlson, and J. S. Powell. 1994. Gene expression following direct injection of DNA into liver. Hum. Gene Ther. 5:1477-1483.
26. Hunninghake, G. W., M. M. Monick, B. Liu, and M. F. Stinski. 1989. The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP response elements. J. Virol. 63:3026-3033.
27. Jennings, G. S., J. Bartkova, S. Herwig, J. Lukas, J. Bartek, and M. Strauss. Submitted for publication.
28. Kay, M. A., Q. Li, T.-J. Liu, F. Leland, C. Toman, M. Finegold, and S. Woo. 1992. Hepatic gene therapy: persistent expression of human α1-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3:641-647.
29. Kay, M. A., S. Rothenberg, C. N. Landen, D. A. Bellinger, F. Leland, C. Toman, M. Finegold, A. R. Thompson, M. S. Read, K. M. Brinkhous, and S. L. C. Woo. 1993. In vivo correction of hemophelia B: sustained partial correction in factor IX-deficient dogs. Science 262:117-119.
30. fash mice and in OTC-deficient human hepatocytes with recombinant adenovirus bearing the CAG promoter. Hum. Gene Ther. 7:821-830.
31. Koedodd, M., A. Fichtel, P. Meier, and P. J. Mitchell. 1995. Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV injection. J. Virol. 69:2194-2207.
32. Kothari, S., J. Baullie, J. G. P. Sissons, and J. H. Sinclair. 1991. The 21 bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells. Nucleic Acids Res. 29:1767-1771.
33. Kowalik, T. F., B. Wing, J. S. Haskill, J. C. Azizkhan, A. S. Baldwin, Jr., and E. S. Huang. 1993. Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 90:1107-1111.
34. Krappmann, D., F. G. Wulczyn, and C. Scheidereit. 1996. Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IkBα in vivo. EMBO J. 15:6716-6726.
35. Lang, D., H. Fickenscher, and T. Stamminger. 1992. Analysis of proteins binding to the proximal promoter region of the human cytomegalovirus IE-1/2 enhancer/promoter reveals both consensus and aberrant recognition sequences for transcription factors Sp1 and CREB. Nucleic Acids Res. 20:3287-3295.
36. Lieber, A., V. Sandig, and M. Strauss. 1993. A mutant T7 phage promoter is specifically transcribed by T7-RNA polymerase in mammalian cells. Eur. J. Biochem. 217:387-394.
37. Liu, R., J. Baillie, J. G. P. Sissons, and J. H. Sinclair. 1994. The transcription factor YY1 binds to negative regulatory elements in the human cytomegalovirus major immediate early enhancer/promoter and mediates repression in non-permissive cells. Nucleic Acids Res. 22:2453-2459.
38. Löser, P., V. Sandig, I. Kirillova, and M. Strauss. 1996. Evaluation of HBV promoters for use in hepatic gene therapy. Biol. Chem. Hoppe-Seyler 377: 187-193.
39. McElvaney, N. G., and R. G. Crystal. 1995. IL-6 release and airway administration of human CFTR cDNA adenovirus vector. Nat. Med. 1:182-184.
40. Miyanohara, A., P. A. Johnson, R. L. Elam, Y. Dai, J. L. Witztum, I. M. Verma, and T. Friedmann. 1992. Direct gene transfer to the liver with herpes simplex virus type I vectors: transient production of physiologically relevant levels of circulating factor IX. New Biol. 4:238-246.
41. Muiznieks, I., and W. Doerfler. 1994. The impact of 5′-CG-3′ methylation on the activity of different eukaryotic promoters: a comparative study. FEBS Lett. 344:251-254.
42. Müller, U., T. Kleinberger, and T. Shenk. 1992. Adenovirus E4orf4 protein reduces phosphorylation of c-Fos and E1A proteins while simultaneously reducing the level of AP-1. J. Virol. 66:5867-5878.
43. Naumann, M., and C. Scheidereit. 1994. Activation of NF-kappa B in vivo is regulated by multiple phosphorylations. EMBO J. 13:4597-4607.
44. Niller, H. H., and L. Hennighausen. 1991. Formation of several specific nucleoprotein complexes on the human cytomegalovirus immediate early enhancer. Nucleic Acids Res. 19:3715-3721.
45. Pahl, H. L., M. Sester, H.-G. Burgert, and P. A. Baeuerle. 1996. Activation of transcription factor NF-κB by the adenovirus E3/19K protein requires its ER retention. J. Cell Biol. 132:511-522.
46. Paul, D. 1988. Immortalized differenciated hepatocyte lines derived from transgenic mice harbouring SV40-T-antigen. Exp. Cell Res. 175:354-362.
47. Prösch, S., K. Staak, J. Stein, C. Liebenthal, T. Stamminger, H.-D. Volk, and D. H. Krüger. 1995. Stimulation of the human cytomegalovirus IE enhancer/ promoter in HL-60 cells by TNFα is mediated via induction of NF-κB. Virology 208:197-206.
48. Prösch, S., J. Stein, K. Staak, C. Liebenthal, H.-D. Volk, and D. H. Krüger. 1996. Inactivation of the very strong HCMV immediate early promoter by DNA CpG methylation in vitro. Biol. Chem. Hoppe-Seyler 377:195-201.
49. Sambucetti, L. C., J. M. Cherrington, G. W. G. Wilkinson, and E. S. Mocarski. 1989. NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 8:4251-4258.
50. Sandig, V., P. Löser, A. Lieber, M. A. Kay, and M. Strauss. 1996. HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor gene. Gene Ther. 3:1002-1009.
51. Scharfmann, R., H. Axelrod, and I. M. Verma. 1991. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88:4626-4630.
52. Schmidt, E. V., G. Christoph, R. Zeller, and P. Leder. 1990. The cytomegalovirus enhancer: a pan-active control element in transgenic mice. Mol. Cell. Biol. 10:4406-4411.
53. Sinclair, J. H., J. Baillie, L. A. Byrant, J. A. Taylor-Wiedeman, and J. G. P. Sissons. 1992. Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line. J. Gen. Virol. 73:433-435.
54. Stamminger, T., H. Fickenscher, and B. Fleckenstein. Cell type-specific induction of the major immediate early enhancer of human cytomegalovirus by cyclic AMP. J. Gen. Virol. 71:105-113.
55. Taub, R. 1996. Transcriptional control of liver regeneration. FASEB J. 10:413-427.
56. Tewari, M., P. Dobrzanski, K. L. Mohn, D. E. Cressman, J.-C. Hsu, R. Bravo, and R. Taub. 1992. Rapid induction in regenerating liver of RL/IF-1 (an IκB that inhibits NF-κB, RelB-p50, and c-Rel-p50) and PHF, a novel κB site-binding factor. Mol. Cell. Biol. 12:2898-2908.
57. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. van Antwerp, and S. Miyamoto. 1996. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
58. Wilkinson, G. W. G., and A. Akrigg. 1992. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res. 20:2233-2239.
59. Wolff, G., S. Worgall, N. van Rooijen, W.-R. Song, B.-G. Harvey, and R. G. Crystal. 1997. Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ. J. Virol. 71:624-629.
60. Wulczyn, F. G., D. Krappmann, and C. Scheidereit. 1996. The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation. J. Mol. Med. 74:749-769.
61. Yamada, Y., I. Kirillova, J. P. Peschon, and N. Fausto. 1997. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA 94:1441-1446.
62. Yurochko, A. D., T. F. Kowalik, S. M. Huong, and E. S. Huang. 1995. Human cytomegalovirus upregulatcs NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J. Virol. 69:5391-5400.
63. - transport in cystic fibrosis airway epithelia in vitro: effect of promoter and administration method. Gene Ther. 3:458-465.
64. Zhang, X.-Y., N. M. Inamdar, P. C. Supakar, K. Wu, K. C. Ehrlich, and M. Ehrlich. 1991. Three MDBP sites in the immediate-early enhancer-promoter region of human cytomegalovirus. Virology 182:865-869.
65. Zhang, X.-Y., J.-I. Ni, Z. Saifudeen, C. K. Asiedu, P. C. Supakar, and M. Ehrlich. 1995. Increasing binding of a transcription factor immediately downstream of the cap site of a cytomegalovirus gene represses expression. Nucleic Acids Res. 23:3026-3033.